Evidence map›Paper›PMID 34956991›Full record

ArticleFrontiers in pediatrics2021

Ethical Development of Artificial Amniotic Sac and Placenta Technology: A Roadmap.

E J Verweij, Lien De Proost, Judith O E H van Laar, Lily Frank, Sylvia A Obermann-Borstn, Marijn J Vermeulen, Sophie van Baalen, M Beatrijs van der Hout-van der Jagt, Elselijn Kingma

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Artificial womb technology; a scoping review of ethical considerations.Journal of perinatology : official journal of the California Perinatal Association · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

E J VerweijDivision of Fetal Therapy, Department of Obstetrics, Leiden University Medical Center, Leiden, Netherlands.
Lien De ProostDepartment of Obstetrics and Gynaecology, Erasmus Medical Center (MC), Rotterdam, Netherlands.
Judith O E H van LaarDepartment of Obstetrics and Gynaecology, Máxima Medical Centre, Veldhoven, Netherlands.
Lily FrankDepartment of Industrial Engineering and Innovation Sciences, Eindhoven University of Technology, Eindhoven, Netherlands.
Sylvia A Obermann-BorstnCare4Neo, Rotterdam, Netherlands.
Marijn J VermeulenDepartment of Neonatology, Erasmus Medical Center (MC), Rotterdam, Netherlands.
Sophie van BaalenRathenau Instituut, The Hague, Netherlands.
M Beatrijs van der Hout-van der JagtDepartment of Obstetrics and Gynaecology, Máxima Medical Centre, Veldhoven, Netherlands.
Elselijn KingmaDepartment of Philosophy, King's College London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper we present an initial roadmap for the ethical development and eventual implementation of artificial amniotic sac and placenta technology in clinical practice. We consider four elements of attention: (1) framing and societal dialogue; (2) value sensitive design, (3) research ethics and (4) ethical and legal research resulting in the development of an adequate moral and legal framework. Attention to all elements is a necessary requirement for ethically responsible development of this technology. The first element concerns the importance of framing and societal dialogue. This should involve all relevant stakeholders as well as the general public. We also identify the need to consider carefully the use of terminology and how this influences the understanding of the technology. Second, we elaborate on value sensitive design: the technology should be designed based upon the principles and values that emerge in the first step: societal dialogue. Third, research ethics deserves attention: for proceeding with first-in-human research with the technology, the process of recruiting and counseling eventual study participants and assuring their informed consent deserves careful attention. Fourth, ethical and legal research should concern the status of the subject in the AAPT. An eventual robust moral and legal framework for developing and implementing the technology in a research setting should combine all previous elements. With this roadmap, we emphasize the importance of stakeholder engagement throughout the process of developing and implementing the technology; this will contribute to ethically and responsibly innovating health care.

Indexed as

artificial placentaartificial wombectogenesisectogestationethicsperinatal life supportresearch ethicsvalue sensitive design

Identifiers

PMID34956991
PMCPMC8694243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.